Cutler R G
Gerontology Research Center, National Institute on Aging, Baltimore, Maryland 21224.
Ann N Y Acad Sci. 1991;621:1-28. doi: 10.1111/j.1749-6632.1991.tb16965.x.
A brief overview has been given of the biological nature of human aging processes, where it has been emphasized that, in addition to the diseases of aging, there is also great economic loss as a result of human aging processes that began many years before medical costs related to aging begin to escalate. Because of the ubiquitous nature of aging, reducing the function of essentially all physiological processes, it appears that the only long-term solution to human aging problems is to decrease uniformly the aging rate of the entire body. Although the uniform decrease of aging rate has usually been considered impossible, where emphasis has consequently been placed on diseases of aging by the medically-orientated investigator, there is now at least one theoretical argument, accompanied by some experimental data, that suggests that progress can be made in achieving this goal. This progress has been based on the longevity determinant gene hypothesis predicting the existence of a relatively few key regulatory factors governing aging rate of the entire organism. If this hypothesis is not true, then indeed the prospect for significant intervention into human aging would appear impossible in the near future. Experiments have been briefly reviewed testing the longevity determinant gene hypothesis, the possibility that aging may be a result of dysdifferentiation and if aging rate is determined by mechanisms acting to stabilize the differentiated state of cells. In testing the dysdifferentiation hypothesis of aging, there is not yet much data one way or the other. It is evident, however, that changes in gene expression do occur with age, sometimes involving endogenous retroviruses or oncogenes. Other morphological evidence shows an increase with age in unusual cell type such as metaplasia cells. However, there is considerably more evidence indicating that aging may be a result of genetic instability (as it is in cancer) and that longer-lived species appear to have a more stable genetic apparatus and superior protective mechanisms against reactive oxygen species. There is a striking similarity in this model of aging and models of cancer, and much might be gained in bringing together these two fields of research. Taking all of these data together, as summarized in Table 14, it appears we may be on the right track and that mechanisms acting to protect DNA against oxidative damage may be one class of longevity determinant mechanisms. There is of course much work remaining to be done, some of which is listed in Table 15 in terms of our knowledge and our gaps of knowledge in this field.
本文简要概述了人类衰老过程的生物学本质,强调了除衰老相关疾病外,在与衰老相关的医疗费用开始攀升的许多年前,人类衰老过程就已造成了巨大的经济损失。由于衰老具有普遍性,会降低几乎所有生理过程的功能,因此,解决人类衰老问题的唯一长期办法似乎是统一降低整个身体的衰老速度。尽管人们通常认为统一降低衰老速度是不可能的,因此以医学为导向的研究人员将重点放在了衰老相关疾病上,但现在至少有一个理论观点,并伴有一些实验数据,表明在实现这一目标方面可以取得进展。这一进展基于长寿决定基因假说,该假说预测存在相对较少的关键调控因子,它们控制着整个生物体的衰老速度。如果这个假说不成立,那么在不久的将来,对人类衰老进行重大干预的前景确实看起来是不可能的。本文简要回顾了检验长寿决定基因假说的实验、衰老可能是分化异常的结果以及衰老速度是否由作用于稳定细胞分化状态的机制所决定的可能性。在检验衰老的分化异常假说时,目前还没有太多正反两方面的数据。然而,很明显,基因表达确实会随着年龄的增长而发生变化,有时涉及内源性逆转录病毒或癌基因。其他形态学证据表明,随着年龄的增长,异常细胞类型(如化生细胞)会增加。然而,有更多证据表明,衰老可能是遗传不稳定的结果(就像癌症一样),寿命较长的物种似乎具有更稳定的遗传机制和更强的抗氧化应激保护机制。衰老模型与癌症模型有惊人的相似之处,将这两个研究领域结合起来可能会有很多收获。综合所有这些数据(总结在表14中),我们似乎走在了正确的道路上,保护DNA免受氧化损伤的机制可能是一类长寿决定机制。当然,还有很多工作有待完成,表15根据我们在这一领域的知识和知识空白列出了其中的一些工作。